CDNA

CareDx, Inc.

54.28

USD

+0.73

+1.36%

Sep 17, 15:59 UTC -4

Closed

After-Market

54.62

+0.34

+0.63%

CareDx, Inc. Profile

About

CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.

Info & Links

CEO

John W. Hanna

Headquarters

8000 Marina Boulevard, 4th Floor
Brisbane, CA 94005, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

765

CareDx, Inc. Statistics

Valuation Measures

Market Capitalization²

2.83B

Enterprise Value

2.45B

Enterprise Value/EBITDA(ttm)

18.86

Price to Earnings Ratio(ttm)

309.65

Price to Sales(ttm)

5.94

Price to Book(mrq)

6.40

Price to Cash(ytd)

8.08K

Profitability

Gross Margin(ttm)

70.38%

Operating Margin(ttm)

2.12%

Profit Margin(ttm)

21.03%

Return on Equity(ttm)

2.87%

Return on Invested Capital(ttm)

26.07%

Return on Assets(ttm)

2.17%

Income Statement

Revenue(ttm)

458.09M

Revenue Per Share(ttm)

8.85

Gross Profit(ttm)

323.33M

EBITDA(ttm)³

130.05M

Net Income Available to Common(ttm)

111.01M

Diluted EPS(ttm)

2.07

Share Statistics

Beta (5Y Monthly)

2.43

52-Week Change

282.79%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

51.73M

Dividend Yield

0.00%

Float⁴

50.49M

% Held by Insiders

2.40%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

373.64M

Total Cash Per Share(mrq)

7.22

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.58%

Quick Ratio(mrq)

4.51%

Book Value Per Share(mrq)

8.27

Cash Flow

Operating Cash Flow Per Share(ytd)

0.65

Free Cash Flow(ytd)

29.26M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.